North America Apheresis Equipment Market Analysis & Forecasts to 2027 - ResearchAndMarkets.com

The "North America Apheresis Equipment Market to 2027 - Regional Analysis and Forecasts By Product; Technology; Procedure; Therapeutic Area; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The North America apheresis equipment market is expected to reach US$ 1,387.38 Mn in 2027 from US$ 755.36 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.

The growth of the apheresis equipment market is primarily attributed to the increasing elderly population and the increasing incidence of hematologic diseases. However, complications associated with apheresis are likely to have a negative impact on market growth. On the other hand, growing medical tourism in Mexico is likely to have a positive impact on the growth of the North America apheresis equipment market in the coming years.

Apheresis is a process in which blood is temporarily removed from the donor's body and separated into various components such as plasma, platelets, red blood cells as well as white blood cells. It is done by centrifugation or membrane separation process. Blood diseases affect one or more parts of the body as well as total health. There are various blood diseases caused by certain genes. Some of the common blood diseases include anemia, hemophilia, von Willebrand disease (VWD), blood cancers such as myeloma, leukemia-lymphoma and others. The rising number of these diseases demands the need for a blood transfusion which is expected to increase the requirement of apheresis equipment, thereby bolstering the growth of the market.

Anemia is known to be the common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans. For instance, according to the Centers for Diseases Control and Prevention (2017), approx. 5,382 deaths were estimated due to the anemia incidences in the U.S. Two of the most common types of apheresis used for the removal of a harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, multiple sclerosis and others. Cytapheresis is a process that removes an excess number of blood cells and is used in the treatment of leukemia, polycythemia and thrombocythemia. Thus, the rising incidence of hematologic diseases is expected to foster the growth of the apheresis equipment market in the region over the coming years.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America apheresis equipment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America apheresis equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

2. North America Apheresis Equipment Market - Key Takeaways

3. North America Apheresis Equipment Market - Market Landscape

3.1 Overview

3.2 Market Segmentation

3.3 PEST Analysis

4. North America Apheresis Equipment Market - Key Market Dynamics

4.1 Key Market Drivers

4.2 Key Market Restraints

4.3 Key Market Opportunities

4.4 Future Trends

4.5 Impact Analysis

5. Apheresis Equipment Market - North America Analysis

5.1 North America Apheresis Equipment Market Revenue Forecasts And Analysis

5.2 Market Positioning

6. North America Apheresis Equipment Market Analysis - By Product

6.1 Overview

6.2 North America Apheresis Equipment Market By Product, 2018 & 2027 (%)

6.3 North America Apheresis Equipment Market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.4 Disposable Apheresis Kits Market

6.5 Apheresis Machine Market

7. North America Apheresis Equipment Market Analysis - By Technology

7.1 Overview

7.2 North America Apheresis Equipment Market, By Technology, 2018 & 2027 (%)

7.3 North America Apheresis Equipment Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

7.4 Centrifugation Market

7.5 Membrane Separation Market

8. North America Apheresis Equipment Market Analysis - By Procedure

8.1 Overview

8.2 North America Apheresis Equipment Market, By Procedure, 2018 & 2027 (%)

8.3 North America Apheresis Equipment Market Revenue And Forecasts to 2027, By Procedure (US$ Mn)

8.4 Plasmapheresis Market

8.5 Photopheresis Market

8.6 Erythrocytapheresis Market

8.7 Leukapheresis Market

8.8 Plateletpheresis Market

8.9 LDL-Apheresis Market

9. North America Apheresis Equipment Market Analysis - By Therapeutic Area

9.1 Overview

9.2 North America Apheresis Equipment Market, By Therapeutic Area, 2018 & 2027 (%)

9.3 North America Apheresis Equipment Market Revenue And Forecasts to 2027, By Therapeutic Area (US$ Mn)

9.4 Haematology Market

9.5 Renal Diseases Market

9.6 Neurology Market

9.7 Other Applications Market

10. North America Apheresis Equipment Market Analysis - By End User

10.1 Overview

10.2 North America Apheresis Equipment Market, By End User, 2018 & 2027 (%)

10.3 North America Apheresis Equipment Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4 Hospitals & Clinics

10.5 Blood Banks/ Blood Donation Centers

10.6 Ambulatory Surgical Centers

11. North America Apheresis Equipment Market Revenue and Forecasts To 2027

11.1 Overview

12. Apheresis Equipment Market - Industry Landscape

12.1 Overview

13. Apheresis Equipment Market-Key Company Profiles

13.1 Medica S.p.A.

13.2 Fresenius Medical Care AG & Co. KGaA

13.3 Asahi Kasei Corporation

13.4 Terumo Corporation

13.5 B. Braun Melsungen AG

13.6 Haemonetics Corporation

13.7 Hemacare Corporation

13.8 Kaneka Medix Corp

13.9 Kawasumi laboratories. Inc.

13.10 medicap clinic GmbH

For more information about this report visit https://www.researchandmarkets.com/r/d8q56m

View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005484/en/